This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Facts about Serine/threonine-protein kinase WNK2.
Activates SLC12A2, SCNN1A, SCNN1B, SCNN1D and SGK1 and inhibits SLC12A5. Negatively regulates the EGF-induced activation of the ERK/MAPK-pathway and the downstream cell cycle progression.
Human | |
---|---|
Gene Name: | WNK2 |
Uniprot: | Q9Y3S1 |
Entrez: | 65268 |
Belongs to: |
---|
protein kinase superfamily |
EC 2.7.11; EC 2.7.11.1; PRK; PRKWNK2; Protein kinase with no lysine 2; SDCCAG43; serine/threonine-protein kinase WNK2; Serologically defined colon cancer antigen 43lysine deficient 2; WNK lysine deficient protein kinase 2
Mass (kDA):
242.676 kDA
Human | |
---|---|
Location: | 9q22.31 |
Sequence: | 9; NC_000009.12 (93184156..93327581) |
Expressed in various cancer cell lines (at protein level). Predominantly expressed in heart, brain, skeletal muscle and colon.
Cytoplasm. Cell membrane.
PMID: 11571656 by Verissimo F., et al. WNK kinases, a novel protein kinase subfamily in multi-cellular organisms.
PMID: 11280764 by Ito M., et al. Molecular basis of T cell-mediated recognition of pancreatic cancer cells.